Evidence map›Paper›PMID 29872506›Full record

ArticleOncotarget2018

Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer.

Yekaterina Y Zaytseva, Piotr G Rychahou, Anh-Thu Le, Timothy L Scott, Robert M Flight, Ji Tae Kim, Jennifer Harris, Jinpeng Liu, Chi Wang, Andrew J Morris and 9 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 1 synthesis or guideline pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Targeting Lipid Metabolism in Cancer Stem Cells for Anticancer Treatment.International journal of molecular sciences · 2024
    Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Yekaterina Y ZaytsevaDepartment of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, USA.
Piotr G RychahouMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.
Anh-Thu LeDepartment of Surgery, University of Kentucky, Lexington, KY, USA.
Timothy L ScottRC-SIRM, University of Kentucky, Lexington, KY, USA.
Robert M FlightRC-SIRM, University of Kentucky, Lexington, KY, USA.
Ji Tae KimMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.
Jennifer HarrisDepartment of Surgery, University of Kentucky, Lexington, KY, USA.
Jinpeng LiuMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.
Chi WangMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.
Andrew J MorrisCardiovascular Research, University of Kentucky, Lexington, KY, USA.
Theru A SivakumaranMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.
Teresa FanRC-SIRM, University of Kentucky, Lexington, KY, USA.
Hunter MoseleyRC-SIRM, University of Kentucky, Lexington, KY, USA.
Tianyan GaoMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.
Eun Y LeeDepartment of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, USA.
Heidi L WeissMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.
Timothy S Heuer3-V Biosciences, Menlo Park, CA, USA.
George Kemble3-V Biosciences, Menlo Park, CA, USA.
Mark EversMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.
University of Kentucky · USMarkey Cancer Center · USPacific Biosciences (United States) · US

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI KATHLEEN L. O'CONNOR · 2013 to 2026
$38.3M
University of Kentucky Center for Cancer MetabolismP20GM121327 · NIGMS · UNIVERSITY OF KENTUCKY · PI Binhua P Zhou · 2017 to 2026
$25.0M
The role of IKKß in linking obesity to adipose tissue inflammation and adipogeneP20GM103527 · NIGMS · UNIVERSITY OF KENTUCKY · PI ABDEL-LATIF, AHMED · 2012 to 2017
$13.7M
SAMPLE COREU24DK097215 · NIDDK · UNIVERSITY OF KENTUCKY · PI FAN, TERESA WHEI-MEI, HIGASHI, RICHARD M · 2013 to 2017
$8.7M
The Role of PHLPP in Colon CancerR01CA133429 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GAO, TIANYAN · 2009 to 2024
$5.6M
Mechanisms Regulating Neurotensin Secretion and FunctionR01DK112034 · NIDDK · UNIVERSITY OF KENTUCKY · PI EVERS, BERNARD MARK · 2017 to 2025
$4.9M
Altered Lipid Metabolism as a Novel Target for Colon Cancer TreatmentR01CA208343 · NCI · UNIVERSITY OF KENTUCKY · PI EVERS, BERNARD MARK, GAO, TIANYAN · 2017 to 2021
$2.1M
Novel pRNA Nanoparticle Delivery as Directed Therapy for Colorectal Cancer MetastasisR01CA195573 · NCI · UNIVERSITY OF KENTUCKY · PI EVERS, BERNARD MARK, GUO, PEIXUAN · 2015 to 2019
$1.8M
Triple Quadrupole Mass Spectrometer SystemS10OD021753 · OD · UNIVERSITY OF KENTUCKY · PI MORRIS, ANDREW J · 2017 to 2017
$352k
The Role of Fatty Acid Synthase in Regulation of Cancer Cells Survival and Metastasis in Colorectal CancerK22CA197193 · NCI · UNIVERSITY OF KENTUCKY · PI ZAYTSEVA, YEKATERINA · 2016 to 2016
$158k
Lysophosphatidic acid and cardiovascular disease riskI01CX001550 · VA · VA MEDICAL CENTER - LEXINGTON, KY · PI MORRIS, ANDREW J · 2017 to 2021
–
CSRD VA I01 CX001550NCI NIH HHS K22 CA197193NCI NIH HHS P30 CA177558NCI NIH HHS R01 CA133429NCI NIH HHS R01 CA195573NCI NIH HHS R01 CA208343NIDDK NIH HHS R01 DK112034NIDDK NIH HHS U24 DK097215NIGMS NIH HHS P20 GM103527NIGMS NIH HHS P20 GM121327NIH HHS S10 OD021753
6 · The paper itself

Abstract

Fatty Acid Synthase (FASN), a key enzyme of

Indexed as

colorectal cancerFASNlipogenesispatient-derived xenograftsTVB-3664

Identifiers

PMID29872506
PMCPMC5973868
OpenAlexW2808019712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.